Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Mortality after transplant for hemoglobinopathies

Broglie L et al. BMT Tandem Meeting, Abstract 16.

Publish date:: March 9, 2018

Key clinical point: HCT-CI scores of 3+ may predict mortality after transplant for nonmalignant disease.

Major finding: Hazard ratios for poor survival were 1.33 for scores of 3-4 and 2.31 for scores of 5 or greater, compared with 1.0 and 1.127 for scores of 0 or 1-2, respectively.

Study details: A review of 4,083 patients from the CIBMTR database.

Disclosures: Dr. Broglie reported having no financial disclosures.

Source: Broglie L et al. BMT Tandem Meeting, Abstract 16.

Read the full article.

Citation:

Broglie L et al. BMT Tandem Meeting, Abstract 16.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

PDAC: Tumor reduction after neoadjuvant therapy may predict postsurgical survival,

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

‘Impressive’ local control with MRI-guided brachytherapy in cervical cancer,

U.S. mothers underestimate role breastfeeding plays in curbing breast cancer,

Must Reads in Cellular Therapy

CAR T-cell therapy may worsen mental health in some patients,

New Toxicity Subscale Measures QOL in Cancer Patients on Checkpoint Inhibitors,

CAR T cells produce complete responses in T-cell malignancies,

CAR T-cell therapy advances in CLL,

Inhibitor appears to strengthen anti-BCMA CAR T cells in myeloma patients,